- Home
- AMRK vs RLAY Comparison
AMRK vs RLAY Comparison
Compare AMRK & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRK
- RLAY
- Stock Information
- Founded
- AMRK 1965
- RLAY 2015
- Country
- AMRK United States
- RLAY United States
- Employees
- AMRK N/A
- RLAY N/A
- Industry
- AMRK Other Specialty Stores
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMRK Industrials
- RLAY Health Care
- Exchange
- AMRK Nasdaq
- RLAY Nasdaq
- Market Cap
- AMRK 698.1M
- RLAY 811.8M
- IPO Year
- AMRK N/A
- RLAY 2020
- Fundamental
- Price
- AMRK $27.63
- RLAY $4.61
- Analyst Decision
- AMRK Strong Buy
- RLAY Strong Buy
- Analyst Count
- AMRK 3
- RLAY 10
- Target Price
- AMRK $46.33
- RLAY $20.11
- AVG Volume (30 Days)
- AMRK 185.4K
- RLAY 2.9M
- Earning Date
- AMRK 02-06-2025
- RLAY 02-20-2025
- Dividend Yield
- AMRK 2.90%
- RLAY N/A
- EPS Growth
- AMRK N/A
- RLAY N/A
- EPS
- AMRK 2.44
- RLAY N/A
- Revenue
- AMRK $9,929,517,000.00
- RLAY $10,006,000.00
- Revenue This Year
- AMRK $10.62
- RLAY N/A
- Revenue Next Year
- AMRK $2.36
- RLAY N/A
- P/E Ratio
- AMRK $11.35
- RLAY N/A
- Revenue Growth
- AMRK 0.59
- RLAY N/A
- 52 Week Low
- AMRK $24.22
- RLAY $3.50
- 52 Week High
- AMRK $47.39
- RLAY $11.16
- Technical
- Relative Strength Index (RSI)
- AMRK 49.99
- RLAY 47.49
- Support Level
- AMRK $27.50
- RLAY $4.25
- Resistance Level
- AMRK $28.71
- RLAY $4.68
- Average True Range (ATR)
- AMRK 0.77
- RLAY 0.45
- MACD
- AMRK 0.16
- RLAY 0.00
- Stochastic Oscillator
- AMRK 59.30
- RLAY 62.58
About AMRK A-Mark Precious Metals Inc.
A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales and Ancillary Services; Secured Lending and Direct-to-Consumer. It generates maximum revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Australia, Africa, and other regions.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).